Shaw PH, Reed DR, Yeager N, Zebrack B, Castellino SM, Bleyer A. Adolescent and young adult (AYA) oncology in the United States: a specialty in its late adolescence. J Pediatr Hematol Oncol 2015; 37: 161–169.
Canner J, Alonzo TA, Franklin J, Freyer DR, Gamis A, Gerbing RB et al. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group. Cancer 2013; 119: 4162–4169.
Woods WG, Franklin AR, Alonzo TA, Gerbing RB, Donohue KA, Othus M et al. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials. Cancer 2013; 119: 4170–4179.
National Cancer Data Base. Available from https://www.facs.org/quality%20programs/cancer/ncdb (accessed date 24 March 2015).
Schemper M, Wakounig S, Heinze G. The estimation of average hazard ratios by weighted Cox regression. Stat Med 2009; 28: 2473–2489.
Li KH, Meng XL, Raghunathan TE, Rubin DB. Significance levels from repeated P-values with multiply-imputed data. Stat Sinica 1991; 1: 65–92.
Rubin DB, Schenker N. Multiple imputation for interval estimation from simple random samples with ignorable nonresponse. J Am Stat Assoc 1986; 81: 366–374.
Stiller CA, Benjamin S, Cartwright RA, Clough JV, Gorst DW, Kroll ME et al. Patterns of care and survival for adolescents and young adults with acute leukaemia—a population-based study. Br J Cancer 1999; 79: 658–665.
Altman JK, Rademaker A, Cull E, Weitner BB, Ofran Y, Rosenblat TL et al. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death. Leuk Res 2013; 37: 1004–1009.
Grimwade D, Burnett AK. Getting to the heart of improving outcomes for patients with acute promyelocytic leukemia. Oncology 2012; 26: 647–649.
Sanz MA, Lo Coco F, Martin G, Avvisati G, Rayon C, Barbui T et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000; 96: 1247–1253.
All-trans retinoic acid (systemic tretinoin): Drug Information. Available from http://www.uptodate.com/contents/all-trans-retinoic-acid-systemic-tretinoin-drug-information?source=search_result&search=vesanoid&selectedTitle=1%7E96#F230429 (accessed date 26 June 2015).